Norvège -
norvégien -
Statens legemiddelverk
conoxia 100 %
linde gas - oksygen - medisinsk gass, komprimert - 100 %
Union européenne -
norvégien -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Union européenne -
norvégien -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Union européenne -
norvégien -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Union européenne -
norvégien -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Norvège -
norvégien -
Statens legemiddelverk
sugammadex baxter 100 mg/ ml
baxter holding b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
Norvège -
norvégien -
Statens legemiddelverk
sugammadex bioglan 100 mg/ ml
bioglan ab - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
Norvège -
norvégien -
Statens legemiddelverk
sugammadex teva 100 mg/ ml
teva b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml
Union européenne -
norvégien -
EMA (European Medicines Agency)
activyl
intervet international bv - indoxacarb - ectoparasiticides for utvortes bruk, inkl. insektmidler, indoxacarb - dogs; cats - behandling og forebygging av loppeangrep. for hunder og katter: behandling og forebygging av loppeangrep. veterinærpreparatet kan brukes som en del av en behandlingsstrategi for loppe-allergi dermatitt. utvikle stadier av lopper i kjæledyrets umiddelbare omgivelser blir drept etter kontakt med activyl-behandlede kjæledyr.